Literature DB >> 6451167

Coronary flow studies in patients with left ventricular hypertrophy of the hypertensive type. Evidence for an impaired coronary vascular reserve.

A D Pichard, R Gorlin, H Smith, J Ambrose, J Meller.   

Abstract

Increased myocardial blood flow occurs in ventricular hypertrophy, but flow per 100 grams of myocardium remains normal. The increase in flow may be obtained at the expense of the existing coronary vascular reserve or by an increase in the vascular bed. The coronary vascular reserve was studied by analyzing the hyperemic reaction to selective injection of contrast agent into the coronary arteries in 25 patients: a control group (9 patients) with chest pain syndrome, normal coronary arteries and a normal left ventricle (Group I) and 16 patients with aortic stenosis, left ventricular hypertrophy and normal coronary arteries (Group II). The hyperemic response in Groups I and II was 73.3 +/- 2.2 and 65.8 +/- 9.1 percent, respectively (difference not significant). Group II was subdivided into two groups: Group IIA had five patients with a left ventricular mass of less than 200 g (mean 158.8 +/- 25.9); this group had a hyperemic response of 102.3 +/- 9.9 percent. Group IIB had 11 patients with a left ventricular mass of more than 200 g (mean 308.9 +/- 22.5) and a hyperemic response of 49.27 +/- 10.42 percent. The hyperemic response was correlated with the diastolic left ventricular-aortic gradient (r = +0.64, p less than 0.001), left ventricular mass (r = -0.51, p less than 0.01) and aortic diastolic pressure (r = +0.636, p less than 0.001). Group I had a left ventricular mass similar to that of Group IIA (124.9 +/- 9 and 158.8 +/- 26 g, respectively) but a lower hyperemic response (73.3 +/- 2 and 102.3 +/- 10 percent, respectively). These data suggest that severe left ventricular hypertrophy is associated with a reduction in coronary vascular reserve; it is speculated that this decrease in the vascular reserve capacity may be related to the ischemic component of hypertrophic heart disease.

Entities:  

Mesh:

Year:  1981        PMID: 6451167     DOI: 10.1016/0002-9149(81)90537-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

Authors:  D J Sheridan; M P Kingsbury; N A Flores
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

2.  Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy.

Authors:  J J Crowley; P S Dardas; A A Harcombe; L M Shapiro
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

3.  Effect of blood pressure lowering on coronary vasodilator reserve in arterial hypertension.

Authors:  R Gistri; A G Ebert; C Palombo; C Marabotti; L Choudhury; P G Camici
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

4.  Possible complications of subclavian crush syndrome.

Authors:  S A M Said; C H J M Ticheler; C M Stassen; A Derks; H T Droste
Journal:  Neth Heart J       Date:  2005-03       Impact factor: 2.380

5.  Contractility reserve in children undergoing dialysis by dobutamine stress echocardiography.

Authors:  Timur Mese; Baris Guven; Murat Muhtar Yilmazer; Erkin Serdaroglu; Vedide Tavli; Ali Haydar; Mustafa Bak
Journal:  Pediatr Cardiol       Date:  2010-05-19       Impact factor: 1.655

6.  Profiles of coronary blood flow velocity in patients with aortic stenosis and the effect of valve replacement: a transthoracic echocardiographic study.

Authors:  A Kenny; C R Wisbey; L M Shapiro
Journal:  Br Heart J       Date:  1994-01

7.  Loss of endothelial KATP channel-dependent, NO-mediated dilation of endocardial resistance coronary arteries in pigs with left ventricular hypertrophy.

Authors:  Marie-Eve Gendron; Eric Thorin; Louis P Perrault
Journal:  Br J Pharmacol       Date:  2004-08-23       Impact factor: 8.739

Review 8.  Regional myocardial blood flow and coronary reserve in hypertensive patients. The effect of therapy.

Authors:  O Parodi; D Neglia; G Sambuceti; C Marabotti; C Palombo; L Donato
Journal:  Drugs       Date:  1992       Impact factor: 9.546

9.  Complete reversibility of physiological coronary vascular abnormalities in hypertrophied hearts produced by pressure overload in the rat.

Authors:  S Isoyama; N Ito; M Kuroha; T Takishima
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

10.  Inadequate Blood Pressure Control in Hypertensive Patients Referred for Cardiac Stress Test.

Authors:  Tarek M Mousa; Oluwaseun A Akinseye; Todd C Kerwin
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-05-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.